Skip to main content

Share repurchase programme: Transactions of week 31 2026

The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 3 billion, cf. Corporate Announcement No. 11/2026 of 5 February 2026. The share repurchase programme is initiated and structured in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 1,584,918 918.65 1,455,986,53927 July 2026 11,227 1.012.13 11,363,16228 July 2026 11,740 1.005.55 11,805,10229 July 2026 11,565 1.003.71 11,607,91830...

Continue reading

WeRide and GreenMobility Announce Strategic Partnership to Advance Level 4 Autonomous Mobility in Denmark, Marking WeRide’s Entry into the Nordic Region

COPENHAGEN, Denmark, Aug. 03, 2026 (GLOBE NEWSWIRE) — WeRide (Nasdaq: WRD, HKEX: 0800), a global leader in autonomous driving technology, and GreenMobility (Nasdaq Copenhagen: GREENM), Denmark’s leading shared electric mobility provider, today announced a strategic partnership to deploy autonomous shared mobility services in Denmark. The partnership combines WeRide’s globally validated Level 4 autonomous driving technology with GreenMobility’s leading local fleet operations and shared mobility expertise, making the companies the first to pursue commercial autonomous mobility deployment in Denmark, subject to regulatory approvals.Illustration of WeRide and GreenMobility’s GXR in Copenhagen Under the partnership, the companies aim to launch public service in the first half of 2027, and all riders will be...

Continue reading

Ageas sells its stake in Maybank Ageas Holdings Berhad to its JV partner Maybank for EUR 1.1 billion

Regulated information • Inside information    Ageas sells its stake in Maybank Ageas Holdings Berhad to its JV partner Maybank for EUR 1.1 billion Today Ageas announces it has reached an agreement with Malayan Banking Berhad (Maybank) to sell its 30.95% stake in the share capital of Maybank Ageas Holdings Berhad (MAHB) for a total cash consideration equivalent to EUR 1.1 billion1. Ageas entered the Malaysian market in 2001 through a Joint Venture (JV) with Maybank and expanded its activities into Singapore in 2014. The company, operating under the Etiqa brand, occupies the number one position in Non-Life Takaful and holds market leading positions in Life and Non-Life Insurance in Malaysia. In 2025, the JV generated a Net Operating Result of EUR 64 million and has remitted EUR 21 million to the Group. Ageas agreed to sell its stake in...

Continue reading

Leads Biolabs’ PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

NANJING, China, Aug. 02, 2026 (GLOBE NEWSWIRE) — Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has approved the investigational new drug (IND) application for an open-label, multicenter Phase Ib/II clinical trial of its proprietary PD-L1/4-1BB bispecific antibody, Opamtistomig (LBL-024), in combination therapy for metastatic colorectal cancer (mCRC). The study is designed to evaluate the safety and efficacy of Opamtistomig combination regimens in patients with mCRC and to explore potential predictive biomarkers. This marks an important step in expanding the indications for Opamtistomig in gastrointestinal cancers, extending the company’s immuno-oncology footprint from biliary...

Continue reading

Another batch of high-grade assays for FireFly’s resource update and economic studies

Latest high-grade results such as 11.5m @ 11.1% copper and 2.1g/t gold (13.2% CuEq) are expected to form part of the production profile for the early years of a Green Bay re-start KEY POINTSLatest drilling at Green Bay has returned more results which demonstrate the exceptional quality of the high-grade zones which will drive production when operations are resumed The upper VMS zones continue to deliver high-grade copper and gold intersections, including:11.5m @ 13.2% CuEq (11.1% Cu & 2.1g/t Au) in hole MUG26-101 (~ true thickness) 18.9m @ 8.2% copper equivalent (CuEq)1  (7.0% Cu & 1.3g/t Au) and a further zone of 11.1m @ 12.1% CuEq (9.5% Cu & 2.4g/t Au) in hole MUG26-079 (~ true thickness) 13.5m @ 11.1% CuEq (8.4% Cu & 2.6g/t Au) and a further zone of 18.9m @ 7.0% CuEq (6.3% Cu & 0.8g/t Au) in hole MUG26-083...

Continue reading

Verisk Estimates Insured Losses from Kumamoto Earthquake in Japan Will Range Between JPY 220 Billion (~USD 1.4 Billion) and JPY 340 Billion (~USD 2.1 Billion)

Estimate captures insured property losses from ground shaking and liquefaction and are before any recoveries under Japan’s earthquake insurance program BOSTON, Aug. 02, 2026 (GLOBE NEWSWIRE) —  The Catastrophe and Risk Solutions group at Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology provider to the global insurance industry, estimates insured losses of between JPY 220 billion (approximately USD 1.4 billion) and JPY 340 billion (approximately USD 2.1 billion) from the magnitude 6.8 earthquake that struck near Kumamoto City on Japan’s Kyushu Island on July 28. According to the U.S. Geological Survey (USGS), the earthquake occurred south of Kumamoto at a shallow depth of approximately 10 kilometers and resulted from shallow strike-slip faulting within the Eurasian Plate. The event struck a region...

Continue reading

Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

Appointments put dedicated leadership behind two separate priorities: building Ascentage Pharma’s own commercial organization in the United States, and expanding its global business development program ROCKVILLE, Md., Aug. 02, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, today announced the appointment of Faiçal Miyara, PhD, as Chief Business Officer (CBO), responsible for the Company’s global business development, and Jim Ziegler as Chief Commercial Officer (CCO), responsible for the commercialization of the Company’s products in the United States and other countries outside of China. Together, the appointments...

Continue reading

XFLT Shareholders: Vote Today to Approve the King Street Sub-Adviser

A Compelling Majority of Engaged Shareholders Voted “FOR” the King Street Sub-Adviser, Following Recommendations of Leading Independent Proxy Advisory Firms ISS and Glass Lewis Ahead of the August 6th Meeting, XFLT Asks Shareholders to Vote Today on the WHITE Proxy Card “FOR” the King Street Sub-Advisory Agreement CHICAGO, Aug. 02, 2026 (GLOBE NEWSWIRE) — XAI Floating Rate & Alternative Income Trust (XFLT) (the “Fund”) reminds shareholders to vote today on the WHITE proxy card “FOR” the long-term appointment of interim sub-adviser Rockford Tower Asset Management, L.L.C. (the “King Street Sub-Adviser”), a wholly owned subsidiary of King Street Capital Management, L.P. (“King Street”), ahead of the reconvened Special Meeting of Shareholders on August 6, 2026. A vote today on the WHITE proxy card “FOR” the King Street Sub-Adviser...

Continue reading

XFLT Urges Shareholders to Vote Today to Approve the King Street Sub-Advisory Agreement

The Board’s Comprehensive Liquidity Program is Designed to Unlock Shareholder Value Ahead of the August 6th Meeting, XFLT Asks Shareholders to Vote Today on the WHITE Proxy Card “FOR” the King Street Sub-Advisory Agreement CHICAGO, Aug. 01, 2026 (GLOBE NEWSWIRE) — XAI Floating Rate & Alternative Income Trust (XFLT) (the “Fund”) urges shareholders to vote today on the WHITE proxy card “FOR” the long-term appointment of interim sub-adviser Rockford Tower Asset Management, L.L.C. (the “King Street Sub-Adviser”), a wholly owned subsidiary of King Street Capital Management, L.P. (“King Street”) (the “King Street Sub-Advisory Agreement”), ahead of the reconvened Special Meeting of Shareholders on August 6, 2026. Beginning July 30th, the King Street Sub-Adviser assumed the role of sub-adviser and has been engaging with XA Investments...

Continue reading

Scripps completes acquisition of WTVQ in Lexington

CINCINNATI, Aug. 01, 2026 (GLOBE NEWSWIRE) — The E.W. Scripps Company (NASDAQ: SSP) has completed its previously announced acquisition of WTVQ, the ABC affiliate in Lexington, Kentucky, from Morris Network, Inc. for $15.8 million. The acquisition creates a duopoly in Lexington with Scripps’ existing NBC affiliate, WLEX, strengthening the company’s local media presence in Central Kentucky. The completion of the WTVQ acquisition is part of Scripps’ broader strategy to optimize and strengthen its local television portfolio through strategic acquisitions, divestitures and station transactions. This year, Scripps has completed sales of WFTX in Fort Myers, Florida, and WRTV in Indianapolis, generating combined gross proceeds of $123 million. The company also recently completed a station swap with Gray Media that expanded Scripps’ presence...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.